Enhanced Surveillance of COVID-19 in Scotland Edit

This dataset shows the latest results of the Public Health Scotland (PHS) serology surveillance programme. The PHS serology surveillance programme uses existing blood samples within community healthcare and other settings to estimate the proportion of people who have antibodies to coronavirus ("seroprevalence") in the general population of Scotland and to see if this changes over time. Antibodies can be used to identify individuals who have had COVID-19 infection in the past or have developed antibodies as a result of vaccination.\r\n\r\nThis data is also available on the Enhanced Surveillance of Covid-19 in Scotland Dashboard along with detailed commentary and background information on interpreting the data. The dashboard can be accessed from the Enhanced Surveillance of Covid-19 in Scotland publication page. The date of the next release can be found on our list of forthcoming publications. Additional data sources relating to this topic area are provided in the Links section of the Metadata below. Information on COVID-19, including stay at home advice for people who are self-isolating and their households, can be found on NHS Inform.\r\n\r\n__Revisions have been made to our antenatal data: from week beginning 7th June 2021 (ISO week 23 of 2021), we can detect which antibodies are from vaccination and which are from infection (+/- vaccination). These changes can be seen in the dashboard publications from 10th November 2021 onwards. More detail regarding these changes can be found in the notes section of the dashboard.__

Resources

• Seroprevalence by Health Board CSV (Details)
• Seroprevalence by Age CSV (Details)
• Seroprevalence by Sex CSV (Details)

Additional Info